Lmr Partners LLP Cytom X Therapeutics, Inc. Transaction History

Lmr Partners LLP

  • $10.9 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$1.21 - $5.13 $3,872 - $16,416
-3,200 Reduced 17.54%
15,046 $18,000
Q1 2024

May 15, 2024
BUY
$1.41 - $2.74 $25,726 - $49,994
18,246 New
18,246 $39,000
Q2 2022

Aug 15, 2022
BUY
$1.53 - $2.89 $35,395 - $66,857
23,134 New
23,134 $42,000

Others Institutions Holding CTMX

# of Institutions
69
Shares Held
50.4M
Call Options Held
112K
Put Options Held
8.3K
View Full List

About CytomX Therapeutics, Inc.

CTMX Quotes by TradingView
  • Ticker CTMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,950,200
  • Market Cap $66M
  • Description
  • CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...
More about CTMX
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email